6CCW | pdb_00006ccw

Hybrid-2 form Human Telomeric G Quadruplex in Complex with Epiberberine

  • Classification: DNA
  • Organism(s): Homo sapiens
  • Mutation(s): No 

  • Deposited: 2018-02-07 Released: 2018-06-20 
  • Deposition Author(s): Lin, C., Yang, D.Z.
  • Funding Organization(s): National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)

Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 30 
  • Conformers Submitted: 15 
  • Selection Criteria: structures with the least restraint violations 

wwPDB Validation 3D Report Full Report

Validation slider image for 6CCW

This is version 2.2 of the entry. See complete history

Literature

Molecular Recognition of the Hybrid-2 Human Telomeric G-Quadruplex by Epiberberine: Insights into Conversion of Telomeric G-Quadruplex Structures.

Lin, C.Wu, G.Wang, K.Onel, B.Sakai, S.Shao, Y.Yang, D.

(2018) Angew Chem Int Ed Engl 57: 10888-10893

  • DOI: https://doi.org/10.1002/anie.201804667
  • Primary Citation Related Structures: 
    6CCW

  • PubMed Abstract: 

    Human telomeres can form DNA G-quadruplex (G4), an attractive target for anticancer drugs. Human telomeric G4s bear inherent structure polymorphism, challenging for understanding specific recognition by ligands or proteins. Protoberberines are medicinal natural-products known to stabilize telomeric G4s and inhibit telomerase. Here we report epiberberine (EPI) specifically recognizes the hybrid-2 telomeric G4 predominant in physiologically relevant K + solution and converts other telomeric G4 forms to hybrid-2, the first such example reported. Our NMR structure in K + solution shows EPI binding induces extensive rearrangement of the previously disordered 5'-flanking and loop segments to form an unprecedented four-layer binding pocket specific to the hybrid-2 telomeric G4; EPI recruits the (-1) adenine to form a "quasi-triad" intercalated between the external tetrad and a T:T:A triad, capped by a T:T base pair. Our study provides structural basis for small-molecule drug design targeting the human telomeric G4.


  • Organizational Affiliation
    • Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue Center for Cancer Research, Purdue University, West Lafayette, IN, 47906, USA.

Macromolecule Content 

  • Total Structure Weight: 8.54 kDa 
  • Atom Count: 570 
  • Modeled Residue Count: 26 
  • Deposited Residue Count: 26 
  • Unique nucleic acid chains: 1

Macromolecules

Find similar nucleic acids by:  (by identity cutoff) 
Entity ID: 1
MoleculeChains LengthOrganismImage
DNA (26-MER)26Homo sapiens
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
EWV

Query on EWV



Download:Ideal Coordinates CCD File
B [auth A]Epiberberine
C20 H18 N O4
FPJQGFLUORYYPE-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 30 
  • Conformers Submitted: 15 
  • Selection Criteria: structures with the least restraint violations 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2018-06-20
    Type: Initial release
  • Version 1.1: 2018-10-17
    Changes: Data collection, Database references
  • Version 2.0: 2019-12-18
    Changes: Atomic model, Author supporting evidence, Data collection
  • Version 2.1: 2023-06-14
    Changes: Database references, Other
  • Version 2.2: 2024-05-15
    Changes: Data collection, Database references